Evidence map›Paper›PMID 38684699›Full record

ArticleCell discovery2024

Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue.

Jiaying Wu, Tuo Li, Meng Guo, Junsong Ji, Xiaoxi Meng, Tianlong Fu, Tengfei Nie, Tongkun Wei, Ying Zhou, Weihua Dong and 5 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
47.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Pancreatic injury induces β-cell regeneration in axolotl.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Engineering hypoimmune stem cell-derived beta cells.Stem cell research & therapy · 2025
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Jiaying Wu *Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Tuo Li *Department of Endocrinology, Shanghai Changzheng Hospital (Second Affiliated Hospital of Naval Medical University), Shanghai, China.ORCID http://orcid.org/0000-0002-6691-7423
Meng Guo *National Key Laboratory of Medical Immunology & Institute of Immunology, Naval Medical University, Shanghai, China.
Junsong Ji *Organ Transplant Center, Shanghai Changzheng Hospital, Shanghai, China.
Xiaoxi Meng *Department of Interventional Radiology, Shanghai Changzheng Hospital, Shanghai, China.
Tianlong Fu *Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Tengfei Nie *Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Tongkun Wei *Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Ying ZhouShanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Weihua DongDepartment of Interventional Radiology, Shanghai Changzheng Hospital, Shanghai, China. dongweihua@smmu.edu.cn.
Ming ZhangDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. drmingzhang@126.com.
Yongquan ShiDepartment of Endocrinology, Shanghai Changzheng Hospital (Second Affiliated Hospital of Naval Medical University), Shanghai, China. young.stone@smmu.edu.cn.
Xin ChengShanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China. xcheng@sibcb.ac.cn.
Hao YinOrgan Transplant Center, Shanghai Changzheng Hospital, Shanghai, China. yinhaoshanghai@163.com.
Clinical Group
Shanghai Changzheng Hospital · CNChinese Academy of Sciences · CNSecond Military Medical University · CNCenter for Excellence in Molecular Cell Science · CNRenji Hospital · CNShanghai Cell Therapy Research Institute · CN

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2017YFA0102702National Natural Science Foundation of China (National Science Foundation of China) 81500447National Natural Science Foundation of China (National Science Foundation of China) 82070798National Natural Science Foundation of China (National Science Foundation of China) 82071799Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission) 22ZR1477300
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38684699
PMCPMC11058776
OpenAlexW4396498266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.